Ustekinumab
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Ustekinumab and local guidelines before prescribing.
Biologic (IL-12/23)
Mechanism
IL-12/23 monoclonal antibody.
Uses
Psoriasis, psoriatic arthritis, Crohn disease, ulcerative colitis.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Infections, injection-site reactions, headache.
Interactions
Live vaccines contraindicated.
Contraindications and cautions
Active infection
Monitoring
TB screen, infection
Pregnancy and breastfeeding
Limited data
Renal and hepatic impairment
No adjustment
Overdose and reversal
Supportive
Special advice
TB screening before starting; fewer infections than anti-TNF.
More from the textbook: uses, cautions and other points
- Adalimumab / secukinumab / ustekinumab / risankizumab | Biologics for severe psoriasis; TB and hepatitis screening.
Dermatology: Skin basics, eczema and psoriasis - Ustekinumab ; risankizumab , mirikizumab , guselkumab | IL-12/23; IL-23 | Crohn's and UC; generally well tolerated; IV induction then SC maintenance
Gastroenterology: Anatomy Physiology Pharmacology - Vedolizumab / ustekinumab | Gut-selective integrin / IL-12/23 blockade.
Gastroenterology: Anatomy Physiology Pharmacology - Biologics (anti-TNF, ustekinumab, vedolizumab) under the IBD team.
Gastroenterology: Gastroenterology Emergencies (Complete) - Ustekinumab , risankizumab , mirikizumab , guselkumab .
Gastroenterology: Inflammatory Bowel Disease - Anti-TNF , vedolizumab and ustekinumab - usually continued throughout, sometimes with timing adjusted in the third trimester.
Gastroenterology: Inflammatory Bowel Disease - Ustekinumab / risankizumab / mirikizumab / guselkumab | IL-12/23 or IL-23 blockers; IV induction, then subcutaneous.
Gastroenterology: Inflammatory Bowel Disease - IL-12/23 and IL-23 inhibitors - ustekinumab, guselkumab, risankizumab, tildrakizumab.
Dermatology: Skin basics, eczema and psoriasis
Where it is discussed in the book
- Gastroenterology: Anatomy Physiology Pharmacology (2 mentions)
- Gastroenterology: Gastroenterology Emergencies (Complete) (1 mention)
- Gastroenterology: Inflammatory Bowel Disease (3 mentions)
- Dermatology: Skin basics, eczema and psoriasis (2 mentions)
- Rheumatology Anatomy Physiology Pharmacology (1 mention)
- Rheumatology: assessment, investigations and drugs (1 mention)
- Clinical Immunology: Immune system basics and immunological investigations (2 mentions)
- Clinical Immunology: Biologics, immunotherapy, checkpoint toxicity and transplant immunology (2 mentions)
- Cell Biology: Cell cycle, signalling, cell death and stem cells (1 mention)